Log In
BCIQ
Print this Print this
 

FB825

  Manage Alerts
Collapse Summary General Information
Company Fountain Biopharma Inc.
Description mAb targeting the C epsilon mX domain of IgE
Molecular Target IgE
Mechanism of ActionAntibody; Antibody dependent cellular cytotoxicity (ADCC)
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today